ENTITY
MicroPort NeuroScientific

MicroPort NeuroScientific (2172 HK)

57
Analysis
Health Care • China
MicroPort NeuroScientific is engaged in the research, development, and manufacturing of neuro-interventional medical devices. The company's products address three key areas of cerebrovascular disease: hemorrhagic stroke, cerebral atherosclerotic stenosis, and acute ischemic stroke. Key products include the NUMEN coil, Tubridge flow-diverting stent, and APOLLO intracranial stent. Headquartered in Shanghai, China, the company was founded in 2012.
more
Exchange Announcement • 24 Sep 2026 08:00

Voluntary Announcement - Nuwismen Liquid Embolic Agent Enters The Innovative Green Path Of Nmpa

Exchange Announcement • 01 Sep 2026 08:56

Inside Information (I) Delay In Publication Of 2026 Interim Results And Possible Delay In Publication Of 2026 Interim Report; (Ii) Postponement Of The Board Meeting; And (Iii) Suspension Of Trading

Exchange Announcement • 01 Sep 2026 08:50

Exchange Notice - Suspension Of Trading

Exchange Announcement • 26 Aug 2026 22:44

Postponement Of Board Meeting

Exchange Announcement • 21 Aug 2026 20:23

Next Day Disclosure Return

x